Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction

European Heart Journal

Volumn 24, Issue 22, 2003, Pages 2012-2020

  Herrerosa, Jesús ^a   Prósper, Felipe ^a   Perez, Ana ^a   Gavira, Juan J ^a   Garcia Velloso, María José ^a   Barba, Joaquín ^a   Sánchez, Pedro L ^b   Cañizo, Consuelo ^b   Rábago, Gregorio ^a   Martí Climent, Josep M ^a   Hernández, Milagros ^a   López Holgado, Natalia ^b   González Santos, José María ^b   Martin Luengo, Cándido ^b   Alegria, Eduardo ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Coronary artery bypass; Non acute myocardia infarction; Skeletal myobtasts

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; AUTOGRAFT; BYPASS SURGERY; CELL VIABILITY; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; HUMAN; MALE; MONONUCLEAR CELL; MYOCARDIAL HIBERNATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; VASTUS LATERALIS MUSCLE;

ADULT; AGED; CELL TRANSPLANTATION; CELLS, CULTURED; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY CIRCULATION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; VENTRICULAR FUNCTION, LEFT;

EID: 10744224982     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.09.012     Document Type: Article

References (39)

1. Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-7.
2. Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 2002;415:240-3.
3. Perin EC, Geng YJ, Willerson JT. Adult stem cell therapy in perspective. Circulation 2003;107:935-8.
4. Brehm M, Zeus T, Strauer BE. Stem cells - clinical application and perspectives. Herz. 2002;27:611-20.
5. Klug MG, Soonpaa MH, Koh GY et al. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 1996;98:216-24.
6. Yokomuro H, Li RK, Mickle DA et al. Transplantation of cryopreserved cardiomyocytes. J Thorac Cardiovasc Surg 2001;121:98-107.
7. Rajnoch C, Chachques JC, Berrebi A et al. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 2001;121:871-8.
8. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
9. Toma C, Pittenger MF, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8.
10. Kawamoto A, Tkebuchava T, Yamaguchi J et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003;107:461-8.
11. Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-8.
12. Tse HF, Kwong YL, Chan JK et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;361:47-9.
13. Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-6.
14. Kessler PD, Byrne BJ. Myoblast cell grafting into heart muscle: cellular biology and potential applications. Annu Rev Physiol 1999;61:219-42.
15. Suzuki K, Brand NJ, Smolenski RT et al. Development of a novel method for cell transplantation through the coronary artery. Circulation 2000;102:111359-64.
16. Atkins BZ, Hueman MT, Meuchel JM et al. Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium. J Heart Lung Transplant 1999;18:1173-80.
17. Menasche P, Hagege AA, Scorsin M et al. Myoblast transplantation for heart failure. Lancet 2001;357:279-80.
18. Murry CE, Wiseman RW, Schwartz SM et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512-23.
19. Dorfman J, Duong M, Zibaitis A et al. Myocardial tissue engineering with autologous myoblast implantation. J Thorac Cardiovasc Surg 1998;116:744-51.
20. Ghostine S, Carrion C, Souza LC et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002;106:1131-6.
21. Taylor DA, Atkins BZ, Hungspreugs P et al Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-33.
22. Hagege AA, Carrion C, Menasche P et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003;361:491-2.
23. Chiu RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995;60:12-8.
24. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002;34:241-9.
25. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
26. Perez JE, Waggoner AD, Barzilai B et al. On-line assessment of ventricular function by automatic boundary detection and ultrasonic backscatter imaging. J Am Coll Cardiol 1992;19:313-20.
27. Muzik O, Beanlands R, Wolfe E et al. Automated region definition for cardiac nitrogen-13-ammonia PET imaging. J Nucl Med 1993;34:336-44.
28. Knuuti MJ, Nuutila P, Ruotsalainen U et al. Euglycemic hyper-insulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992;33:1255-62.
29. Muzik O, Beanlands RS, Hutchins GD et al. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 1993;34:83-91.
30. Belles-Isles M, Roy R, Dansereau G et al. Rapid selection of donor myoblast clones for muscular dystrophy therapy using cell surface expression of NCAM. Eur J Histochem 1993;37:375-80.
31. Pagani FD, DerSimonian H, Zawadzka A et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. J Am Coll Cardiol 2003;41:879-88.
32. Pouzet B, Vilquin JT, Hagege AA et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 2001;71:844-50 discussion 850-841.
33. Menasche P, Hagege AA, Vilquin J-T et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-83.
34. Chachques JC, Cattadori B, Herreros J et al. Treatment of heart failure with autologous skeletal myoblasts. Herz 2002;27:570-8.
35. Menasche P. Skeletal muscle satellite cell transplantation. Cardiovasc Res 2003;58:351-7.
36. Reinecke H, MacDonald GH, Hauschka SD et al. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol 2000;149:731-40.
37. Leobon B, Garcin I, Menasche P et al. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 2003;100:7808-11.
38. Altman KC, Shaw LJ, Hachamovitch R et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
39. Assmus B, Schachinger V, Teupe C et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial lnfarction (TOPCARE-AMI). Circulation 2002;106:3009-17.